Application of echocardiography in oncology – practical remarks
Journal Title: OncoReview - Year 2012, Vol 2, Issue 3
Abstract
The paper presents the contemporary use of echocardiography in diagnosis of primary and metastatic tumors of the heart as well as in assessment of cardiovascular risk related to medical and interventional oncological therapy. Authors described the role of echocardiography in qualification for pericardiocentesis, cancer surgery and chemotherapy. The accuracy of echocardiography in evaluation of cardiac function was discussed in the context of recognizing cardiotoxicity of anticancer therapy. The historical and current definitions of iatrogenic myocardial damage and dysfunction were summarized. Finally, key recommendations derived from polish and foreign clinical guidelines for the use of echocardiography in patients with cancer were presented.
Authors and Affiliations
Rafał Mańczak, Sebastian Szmit, Adam Torbicki
Percutaneous vena cava superior angioplasty and stenting as an effective method of treatment in vena cava superior syndrome in the course of lung cancer
Vena cava superior syndrome (VCSS) is a sudden life-threatening condition encountered in patients with neoplasms. The prognosis depends on histopathological diagnosis, severity of clinical symptoms and administered treat...
Jak planuję hormonoterapię u chorego z rakiem gruczołu krokowego – spojrzenie eksperta
Rak gruczołu krokowego w ciągu ostatnich kilkudziesięciu lat stał się jednym z najczęstszych nowotworów u mężczyzn oraz jedną z głównych przyczyn zgonów na nowotwory. Ponieważ jest nowotworem hormonozależnym, od lat 40....
Predicting heart attack in a patient post-radiation therapy using plaque CCTA analysis and serum biomarker test. Case report
Accelerated coronary artery disease (CAD) is a long term manifestation of chest irradiation that may progress to acute myocardial infarction (MI). We report the use of an algorithm-based biomarker test and coronary compu...
Diagnostics and treatment of acromegaly
Acromegaly is a chronic condition caused by excessive growth hormone secretion and secondary elevation of insulin-like growth factor 1 (IGF-1) concentration. Untreated or inappropriately treated disease results in develo...
Octreotide LAR in neuroendocrine tumors - a summary of the experience
Neuroendocrine tumors are a rare and heterogeneous group of neoplasms. Most of the patient is diagnosed with locally advanced or metastatic disease and curative surgery is rarely an option. Somatostatin analogues have b...